A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer

• Published in: Journal of cancer & allied specialties 2024, Vol.10 (1), p.579-579
• Main Authors: Meiller, Timothy F, Fraser, Claire M, Grant-Beurmann, Silvia, Humphrys, Mike, Tallon, Luke, Sadzewicz, Lisa D, Jabra-Rizk, Mary Ann, Alfaifi, Areej, Kensara, Anmar, Molitoris, Jason K, Witek, Matthew, Mendes, William S, Regine, William F, Tran, Phuoc T, Miller, Robert C, Sultan, Ahmed S
• Format: Article
• Language: English
• Subjects: Head and Neck Cancer; metagenome; oral microbiome; Original; radiation therapy
• ISSN: 2411-989X; 2411-989X
• DOI: 10.37029/jcas.v10i1.579

Due to the radiation-sparing effects on salivary gland acini, changes in the composition of the oral microbiome may be a driver for improved outcomes in patients receiving proton radiation, with potentially worse outcomes in patients exposed to photon radiation therapy. To date, a head-to-head comparison of oral microbiome changes at a metagenomic level with longitudinal sampling has yet to be performed in these patient cohorts. To comparatively analyze oral microbiome shifts during head and neck radiation therapy, a prospective pilot cohort study was performed at the Maryland Proton Treatment Center and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. A longitudinal metagenomic comparative analysis of oral microbiome shifts was performed at three time points (pre-radiation, during radiation, and immediately post-radiation). Head and neck cancer patients receiving proton radiation ( = 4) were compared to photon radiation ( = 4). Additional control groups included healthy age- and sex-matched controls ( = 5), head and neck cancer patients who never received radiation therapy ( = 8), and patients with oral inflammatory disease ( = 3). Photon therapy patients presented with lower microbial alpha diversity at all timepoints, and there was a trend towards reduced species richness as compared with proton therapy. Healthy controls and proton patients exhibited overall higher and similar diversity. A more dysbiotic state was observed in patients receiving photon therapy as compared to proton therapy, in which oral microbial homeostasis was maintained. Mucositis was observed in 3/4 photon patients and was not observed in any proton patients during radiation therapy. The bacterial de novo pyrimidine biosynthesis pathway and the nitrate reduction V pathway were comparatively higher following photon exposure. These functional changes in bacterial metabolism may suggest that photon exposure produces a more permissive environment for the proliferation of pathogenic bacteria. Oral microbiome dysbiosis in patients receiving photon radiation may be associated with increased mucositis occurrence. Proton radiation therapy for head and neck cancer demonstrates a safer side effect profile in terms of oral complications, oral microbiome dysbiosis, and functional metabolic status.